Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 26 Oct 2023 10:00 CEST |
HYBRID SOFTWARE GROUP PLC | Hybrid Software Group releases Q3 results | 10101015 Software | Commercial results |
| 26 Oct 2023 09:43 CEST |
HYBRID SOFTWARE GROUP PLC | HYBRID SOFTWARE GROUP RELEASES Q3 RESULTS | 10101015 Software | Commercial results |
| 26 Oct 2023 07:18 CEST |
BELYSSE GROUP NV | Belysse Group nv Q3 2023 Resultaten | 40202015 Household Furnishings | Other subject |
| 26 Oct 2023 07:16 CEST |
BELYSSE GROUP NV | Belysse Group nv Q3 2023 Results | 40202015 Household Furnishings | Other subject |
| 26 Oct 2023 07:00 CEST |
KINEPOLIS GROUP | Kinepolis zet, na sterke eerste jaarhelft, ook een sterk derde kwartaal neer | 40301010 Entertainment | Commercial results |
| 26 Oct 2023 07:00 CEST |
KINEPOLIS GROUP | Kinepolis reports strong third quarter following strong first half | 40301010 Entertainment | Commercial results |
| 26 Oct 2023 07:00 CEST |
MITHRA | Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada | 20103015 Pharmaceuticals | - |
| 26 Oct 2023 07:00 CEST |
KINEPOLIS GROUP | Après un premier semestre solide, Kinepolis réalise également un solide troisième trimestre | 40301010 Entertainment | Commercial results |
| 25 Oct 2023 22:00 CEST |
MDXHEALTH | MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 | 20103010 Biotechnology | Meetings / events |
| 25 Oct 2023 18:30 CEST |
UMICORE | Umicore - Transparantieverklaring van BlackRock, Inc. | 55201020 Specialty Chemicals | New |
| 25 Oct 2023 18:30 CEST |
UMICORE | Umicore - Transparency notification by BlackRock, Inc. | 55201020 Specialty Chemicals | New |
| 25 Oct 2023 18:30 CEST |
UMICORE | Umicore - Déclaration de transparence par BlackRock, Inc. | 55201020 Specialty Chemicals | New |
| 25 Oct 2023 14:56 CEST |
SHURGARD | 20231024 Shurgard obtains building permit for a site in Utrecht area (Randstad, The Netherlands) | 35101010 Real Estate Holding and Development | New establishment |
| 25 Oct 2023 08:00 CEST |
KBC | KBC Groep: Bericht aan de obligatiehouders van KBC IFIMA | 30101010 Banks | Other subject |
| 25 Oct 2023 08:00 CEST |
OXURION | Oxurion Receives EUR 1.5 Million under Amended Atlas Funding Program; Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial | 20103010 Biotechnology | - |
| 25 Oct 2023 08:00 CEST |
KBC | KBC Group: Notification for bondholders of KBC IFIMA | 30101010 Banks | Other subject |
| 25 Oct 2023 07:00 CEST |
MELEXIS | Melexis Q3 2023 resultaten – Omzet van 248.6 miljoen EUR in het derde kwartaal | 10102010 Semiconductors | Corporate life |
| 25 Oct 2023 07:00 CEST |
MELEXIS | Melexis Q3 2023 results – Third quarter sales of 248.6 million EUR | 10102010 Semiconductors | Corporate life |
| 25 Oct 2023 07:00 CEST |
BIOSENIC | BioSenic provides third quarter 2023 Business Update | 20103010 Biotechnology | Other subject |
| 25 Oct 2023 07:00 CEST |
MELEXIS | Melexis Q3 2023 résultats – Chiffre d'affaires de 248.6 millions d'euros au troisième trimestre | 10102010 Semiconductors | Corporate life |
| 25 Oct 2023 07:00 CEST |
BIOSENIC | BioSenic fait le point sur ses activités du troisième trimestre 2023 | 20103010 Biotechnology | Other subject |
| 24 Oct 2023 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
| 24 Oct 2023 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
| 24 Oct 2023 08:00 CEST |
KBC | KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen | 30101010 Banks | Other subject |
| 24 Oct 2023 08:00 CEST |
KBC | KBC Group: Update regarding the KBC Group share buyback programme | 30101010 Banks | Other subject |
| 24 Oct 2023 08:00 CEST |
KBC | KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe | 30101010 Banks | Other subject |
| 24 Oct 2023 07:00 CEST |
HYLORIS | Hyloris Announces Out-Licensing of Atomoxetine Oral Liquid in Canada | 20103010 Biotechnology | Commercial operations |
| 24 Oct 2023 07:00 CEST |
HYLORIS | Hyloris annonce un accord de licence pour l'Atomoxetine Oral Liquide au Canada | 20103010 Biotechnology | Commercial operations |
| 24 Oct 2023 07:00 CEST |
ARGENX SE | argenx to Report Third Quarter 2023 Financial Results and Business Update on October 31, 2023 | 20103010 Biotechnology | Other subject |
| 23 Oct 2023 18:30 CEST |
UMICORE | Umicore - Déclaration de transparence par Schroders plc | 55201020 Specialty Chemicals | New |
| 23 Oct 2023 18:30 CEST |
UMICORE | Umicore - Transparantieverklaring van Schroders plc | 55201020 Specialty Chemicals | New |
| 23 Oct 2023 18:30 CEST |
UMICORE | Umicore - Transparency notification by Schroders plc | 55201020 Specialty Chemicals | New |
| 23 Oct 2023 18:06 CEST |
GBL | GBL - Transacties op GBL-aandelen 23-10-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 23 Oct 2023 18:05 CEST |
GBL | GBL - Transactions sur actions propres 23-10-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 23 Oct 2023 18:04 CEST |
GBL | GBL - Transactions on GBL shares 23-10-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 23 Oct 2023 18:00 CEST |
VASTNED BELGIUM | Vastned Belgium: Interim statement from the Board of Directors as at 30 September 2023 | 35102045 Retail REITs | Corporate life |
| 23 Oct 2023 18:00 CEST |
VASTNED BELGIUM | Vastned Belgium : Déclaration intermediaire du conseil d'administration au 30 septembre 2023 | 35102045 Retail REITs | Corporate life |
| 23 Oct 2023 18:00 CEST |
VASTNED BELGIUM | Vastned Belgium: Tussentijdse verklaring van de Raad van Bestuur per 30 september 2023 | 35102045 Retail REITs | Corporate life |
| 23 Oct 2023 17:45 CEST |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
| 23 Oct 2023 17:45 CEST |
TITAN CEMENT | Share buyback Programme | 50101030 Cement | Other subject |
| 23 Oct 2023 17:45 CEST |
KINEPOLIS GROUP | Mise à jour concernant le programme de rachat d'actions propres (23 octobre 2023) | 40301010 Entertainment | Corporate life |
| 23 Oct 2023 17:45 CEST |
KINEPOLIS GROUP | Update inkoopprogramma eigen aandelen (23 oktober 2023) | 40301010 Entertainment | Corporate life |
| 23 Oct 2023 17:45 CEST |
KINEPOLIS GROUP | Update share buyback program (23 October 2023) | 40301010 Entertainment | Corporate life |
| 23 Oct 2023 11:00 CEST |
HYBRID SOFTWARE GROUP PLC | Hybrid Software Group PLC: Result of the Extraordinary General Meeting | 10101015 Software | General meeting / Board Meeting |
| 23 Oct 2023 07:29 CEST |
JENSEN-GROUP | Inkoop eigen aandelen - wekelijkse update | 50204000 Machinery: Industrial | Other subject |
| 23 Oct 2023 07:29 CEST |
JENSEN-GROUP | Share buyback – weekly update | 50204000 Machinery: Industrial | Other subject |
| 23 Oct 2023 07:00 CEST |
AZELIS GROUP NV | Azelis Reinforces Its Footprint in the EMEA Flavors & Fragrances Market With the Acquisition of BLH | 55201000 Chemicals: Diversified | Mergers, Acquiqitions, Transferts |
| 23 Oct 2023 07:00 CEST |
MITHRA | Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement | 20103015 Pharmaceuticals | - |
| 20 Oct 2023 22:00 CEST |
MDXHEALTH | Nouveau montant du capital et nouveau nombre d'actions de Mdxhealth | 20103010 Biotechnology | Change in Capital |
| 20 Oct 2023 22:00 CEST |
MDXHEALTH | Mdxhealth's New Share Capital Amount and New Number of Shares | 20103010 Biotechnology | Change in Capital |